Amrize Ltd

RBC Capital Downgrades Amrize (AMRZ)

RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48

RBC Capital analyst Anthony Codling downgrades Amrize (NYSE:AMRZ) from Sector Perform to Underperform and lowers the price target from $60 to $48.

Amrize AG (AMRZ) Q2 2026 Earnings Call Transcript

Amrize AG (AMRZ) Q2 2026 Earnings Call August 7, 2026 8:30 AM EDTCompany ParticipantsBaris Oran - Chief Financial OfficerJan Jenisch - CEO &...

Amrize AG 2026 Q2 - Results - Earnings Call Presentation

2026-08-07. The following slide deck was published by Amrize AG in conjunction with their 2026 Q2 earnings call.

Amrize (NYSE:AMRZ) Slides as Q2 Earnings Miss Overshadows Revenue Growth

Amrize Q2 revenue tops estimates slightly, but EPS misses by 8.2% and stock drops 4.3% on oil-driven cost pressures and weak Building Envelope margins.

Amrize Raises FY2026 Sales Guidance from $12.290B-$12.520B to $12.500B-$12.700B vs $12.464B Est

Amrize (NYSE:AMRZ) raises FY2026 sales outlook from $12.290 billion-$12.520 billion to $12.500 billion-$12.700 billion vs $12.464 billion estimate.

Amrize Q2 Adj. EPS $0.88 Misses $0.94 Estimate, Sales $3.494B Beat $3.365B Estimate

Amrize (NYSE:AMRZ) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $0.94 by 6.38 percent. This is a 12.82 percent increase over earnings of $0.78 per share from the same